Glipizide Tablet
Product Images NDC 51407-620

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Glipizide (NDC 51407-620). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Golden State Medical Supply, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

51407-621-10ol (51407 621 10ol)

Label for Glipizide tablets USP, 10 mg strength. Contains 1,000 tablets, prescription only. The label includes storage instructions (20° - 25°C), dispensing instructions for a child-resistant container, and manufacturer details indicating ANI Pharmaceuticals Canada Inc. and marketed by Golden State Medical Supply, Inc. The NDC is 51407-621-10.*

FDA Label Image

Structure (Image 01)

Chemical structure of Glipizide, showing its molecular arrangement including key functional groups such as a pyridine ring, sulfonylurea moiety, and cyclohexyl group.*

FDA Label Image

Logo (Image 02)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.